Equity Profile

SRRK

Scholar Rock Holding Corporation

Health CareBiotechnology$6.5B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Scholar Rock Holding Corporation is a biotechnology company focused on developing innovative therapies for serious diseases. Operating in the health care sector, its work is particularly relevant as the demand for advanced medical treatments continues to grow.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$-0.82

Revenue

Revenue figures are crucial for understanding the company's market performance and growth potential.

$0M

Wall Street expectations, options signals, track record, and call prep available with Pro.

SRRK Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

13%

Avg EPS Surprise

-11.44%

Avg Stock Reaction

+0.88%

Last Quarter Recap

In Q1-2026, Scholar Rock reported an EPS of $-0.83, slightly missing the consensus estimate of $-0.82. The stock reacted negatively, dropping 1.40% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect another challenging quarter for Scholar Rock, with a consensus EPS loss of $-0.82. The company has not provided specific guidance, leaving investors uncertain about future performance.

Bull Case

If the company can narrow its losses and show signs of revenue generation, it could signal a turnaround, attracting more investor interest.

Bear Case

Continued losses and lack of revenue could lead to further declines in stock price, as investors may lose confidence in the company's ability to deliver on its promises.

Key Metrics to Watch

EPS

$-0.82

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$0M

Revenue figures are crucial for understanding the company's market performance and growth potential.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Scholar Rock be able to report any revenue this quarter?

Revenue generation is critical for demonstrating the company's market viability and could influence investor sentiment significantly.

How does management plan to address the ongoing losses?

Investors will be looking for a clear strategy to improve financial performance and restore confidence in the company's future.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Scholar Rock to generate revenue as it advances its pipeline, which could lead to a surprise in performance this quarter.

Supporting Evidence

The options market is pricing a 13.4% move, indicating expectations of volatility that may not align with the company's actual performance.

Historically, the company has shown resilience in bouncing back from earnings misses, which may not be reflected in current sentiment.

Key Risk

If the company reports any revenue, it could significantly shift investor perception and challenge the current consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it could either reinforce or challenge the company's growth narrative.

Bull Confirmed If

A narrower EPS loss of $-0.66 or better, combined with any revenue generation, would confirm the bull case.

Bear Confirmed If

An EPS loss greater than $-0.94 would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±13.4%

Historical Avg

±5.7%

Pricing rich

The options market is pricing in a significant potential move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±13.4% while SRRK has averaged ±5.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

36.3%

Calls (38K)P/C Ratio: 0.08Puts (6K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Scholar Rock beats expectations and raises guidance, history suggests the stock could see a positive reaction, potentially around a 1.15% increase on the first day.

In-Line / Cautious

If results are in line with expectations but management provides cautious commentary, the stock may remain stable or experience a slight decline.

Miss

A significant miss could lead to a drop in stock price, with history suggesting an average decline of around 1.15% following such outcomes.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on potential revenue generation from ongoing projects.
2Management's strategy for addressing the company's losses.
3Details on the progress of their drug pipeline.
4Insights into market conditions affecting the biotechnology sector.
5Any new partnerships or collaborations that could impact future growth.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$-0.82

Revenue

Revenue figures are crucial for understanding the company's market performance and growth potential.

$0M

Wall Street expectations, options signals, track record, and call prep available with Pro.

SRRK Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

13%

Avg EPS Surprise

-11.44%

Avg Stock Reaction

+0.88%

Last Quarter Recap

In Q1-2026, Scholar Rock reported an EPS of $-0.83, slightly missing the consensus estimate of $-0.82. The stock reacted negatively, dropping 1.40% the next day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If the company can narrow its losses and show signs of revenue generation, it could signal a turnaround, attracting more investor interest.

Bear Case

Continued losses and lack of revenue could lead to further declines in stock price, as investors may lose confidence in the company's ability to deliver on its promises.

Key Metrics to Watch

EPS

$-0.82

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$0M

Revenue figures are crucial for understanding the company's market performance and growth potential.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Scholar Rock be able to report any revenue this quarter?

Revenue generation is critical for demonstrating the company's market viability and could influence investor sentiment significantly.

How does management plan to address the ongoing losses?

Investors will be looking for a clear strategy to improve financial performance and restore confidence in the company's future.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Scholar Rock to generate revenue as it advances its pipeline, which could lead to a surprise in performance this quarter.

Supporting Evidence

The options market is pricing a 13.4% move, indicating expectations of volatility that may not align with the company's actual performance.

Historically, the company has shown resilience in bouncing back from earnings misses, which may not be reflected in current sentiment.

Key Risk

If the company reports any revenue, it could significantly shift investor perception and challenge the current consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is pivotal as it could either reinforce or challenge the company's growth narrative.

Bull Confirmed If

A narrower EPS loss of $-0.66 or better, combined with any revenue generation, would confirm the bull case.

Bear Confirmed If

An EPS loss greater than $-0.94 would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±13.4%

Historical Avg

±5.7%

Pricing rich

The options market is pricing in a significant potential move, indicating that traders expect volatility around the earnings announcement.

Options are pricing ±13.4% while SRRK has averaged ±5.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

36.3%

Calls (38K)P/C Ratio: 0.08Puts (6K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Scholar Rock beats expectations and raises guidance, history suggests the stock could see a positive reaction, potentially around a 1.15% increase on the first day.

In-Line / Cautious

If results are in line with expectations but management provides cautious commentary, the stock may remain stable or experience a slight decline.

Miss

A significant miss could lead to a drop in stock price, with history suggesting an average decline of around 1.15% following such outcomes.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on potential revenue generation from ongoing projects.
2Management's strategy for addressing the company's losses.
3Details on the progress of their drug pipeline.
4Insights into market conditions affecting the biotechnology sector.
5Any new partnerships or collaborations that could impact future growth.